tradingkey.logo

Bristol Myers Expects 2026 Adj EPS $6.05 To $6.35 vs IBES Estimate $6.02

ReutersFeb 5, 2026 12:11 PM

- Bristol-Myers Squibb Co BMY.N:

  • BRISTOL MYERS Q4 ADJUSTED EPS INCLUDES NET IMPACT OF $-0.60 DUE TO ACQUIRED IPRD CHARGES & LICENSING INCOME

  • BRISTOL MYERS Q4 REVENUE $12.5 BILLION VERSUS IBES ESTIMATE $12.28 BILLION

  • BRISTOL MYERS OUTLOOK 2026 REVENUE ABOUT $46.0 BILLION TO $47.5 BILLION VERSUS IBES ESTIMATE $44.16 BILLION

  • BRISTOL MYERS Q4 ADJUSTED EPS $1.26 VERSUS IBES ESTIMATE $1.12

  • BRISTOL MYERS OUTLOOK 2026 ADJUSTED EPS $6.05 TO $6.35 VERSUS IBES ESTIMATE $6.02

  • BRISTOL MYERS OUTLOOK 2026 ELIQUIS WW REVENUE GROWTH 10% - 15%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI